Literature DB >> 23455810

Cytokeratin-positive primitive neuroectodermal tumor of the prostate: case report and review of literature.

Ibrahim Al Haddabi1, Maiya Al Bahri, Ikram Burney.   

Abstract

Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) of the prostate is extremely rare. Here, we report a case of ES/PNET of prostate in a 24-year-old man presenting with dysuria and pelvic discomfort. Computed tomography scan revealed a heterogeneous mass involving the prostate without evidence of distant metastases. Histologically, the tumor was composed of small round blue cells strongly and diffusely positive for CD99 and epithelial markers. Fluorescence in situ hybridization confirmed rearrangement of the Ewing's sarcoma region on chromosome 22.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23455810     DOI: 10.4103/0377-4929.107826

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  4 in total

1.  Primitive neuroectodermal tumor of the prostate in a 58-year-old man: A case report.

Authors:  Da-Wei Tian; Xiao-Chun Wang; Hui Zhang; Yan Tan
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

Review 2.  Peripheral primitive neuroectodermal tumor: dynamic CT, MRI and clinicopathological characteristics--analysis of 36 cases and review of the literature.

Authors:  Yan Tan; Hui Zhang; Guo-Lin Ma; En-Hua Xiao; Xiao-Chun Wang
Journal:  Oncotarget       Date:  2014-12-30

3.  Rapidly progressive primitive neuroectodermal tumor of the prostate: A case report and review of the literature.

Authors:  Tadamasa Shibuya; Kenichi Mori; Yasuhiro Sumino; Fuminori Sato; Hiromitsu Mimata
Journal:  Oncol Lett       Date:  2014-11-24       Impact factor: 2.967

4.  Prostatic sarcoma of the Ewing family in a 33-year-old male - A case report and review of the literature.

Authors:  Lukas Esch; Dimitri Barski; Reinhold Bug; Thomas Otto
Journal:  Asian J Urol       Date:  2015-12-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.